Detalhe da pesquisa
1.
Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.
Cell
; 152(5): 1065-76, 2013 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23452854
2.
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers.
Hepatology
; 77(6): 1943-1957, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052732
3.
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy.
Proc Natl Acad Sci U S A
; 118(45)2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725151
4.
Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences.
Gut
; 72(6): 1196-1210, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596711
5.
Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment.
Cancer Sci
; 114(11): 4286-4298, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688308
6.
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.
Oncology
; 101(11): 730-737, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467732
7.
Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients.
Gastric Cancer
; 26(6): 934-946, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668884
8.
Combining microenvironment normalization strategies to improve cancer immunotherapy.
Proc Natl Acad Sci U S A
; 117(7): 3728-3737, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015113
9.
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.
Gut
; 71(1): 185-193, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431577
10.
VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway.
J Transl Med
; 20(1): 212, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562734
11.
Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers.
Int J Mol Sci
; 23(4)2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216045
12.
Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease.
Chirurgia (Bucur)
; 117(4): 407-414, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36049097
13.
Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.
Hepatology
; 71(4): 1247-1261, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31378984
14.
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases.
Breast Cancer Res Treat
; 179(1): 113-123, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31541381
15.
Scirrhous HCC: Another 'omic thread in the HCC tapestry.
Hepatology
; 79(4): 747-748, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725712
16.
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.
Oncology
; 98(12): 836-846, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33027788
17.
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
Cancer
; 125(13): 2213-2221, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30913304
18.
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.
Proc Natl Acad Sci U S A
; 113(16): 4470-5, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27044097
19.
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.
Proc Natl Acad Sci U S A
; 113(16): 4476-81, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27044098
20.
Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?
Gut
; 72(4): 608-610, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772925